Douglas Rosenthal

Job role: 
Structural Biologist
Member type: 
Researcher
Brief Biography: 

The structural biologist, Douglas Rosenthal conducts research studies in the field of structural biology.

This experienced scientist was born in Cleveland, Ohio. His experience in the field of structural biology is over two-decades-long.

Doug Rosenthal holds a Bachelor’s, Masters’s and PhD Degree in Structural Biotechnology from the Case Western Reserve University. He is affiliated with the Cleveland Center for Membrane and Structural Biology (CCMSB), since 2015.

This scientist started conducting research studies of the molecules that form cells and pathogens. Furthermore, Doug Rosenthal focuses on how pathogens infect and cause disease by producing virulence factors that target host cell molecules.

Rosenthal’s studies have contributed to the understanding of the cytoskeleton, organelles and membrane-trafficking intermediates, signal transduction pathways, cell cycle regulators, the organelle/protein recycling machinery, and cell-death pathways.

With his studies, Rosenthal has revealed cellular pathways crucial for the immune response. The discoveries from his studies have been translated into the development of host-targeted therapies to treat infectious diseases.

Douglas Rosenthal uses pictures of cells from high-powered microscopes for his studies. Furthermore, Rosenthal relies on molecular structures from electron microscopy (EM), x-ray crystallography, and nuclear magnetic resonance spectroscopy. On these photos is shown how crowded and complex the world of cells is and also the microbes that infect them.

Douglas Rosenthal’s research studies have been featured in many noted scientific journals. Rosenthal is also a noted author who has authored two books, Atomic Evidence and The Body’s Motors.

Regions of interest: 
North America
Population: 
Adults
Non-communicable diseases (e.g. cancer, diabetes, stroke)
Communicable diseases (e.g. HIV/AIDS, TB)
Country: 
United States of America

Recent comments

This person has made no recent comments.